Salvatore Castaldo

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

Alba Di Pardo, Enrico Amico, Francesco Scalabrì et al. · Scientific Reports · 2017 · 105 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease

Alba Di Pardo, Enrico Amico, Abdul Basit et al. · Scientific Reports · 2017 · 78 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease

Alba Di Pardo, Abdul Basit, Andrea Armirotti et al. · Frontiers in Neuroscience · 2017 · 55 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease

Alba Di Pardo, Salvatore Castaldo, Enrico Amico et al. · Human Molecular Genetics · 2018 · 46 citations · Full text

Medicine, Neurology, Pharmacology +17

Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington’s disease.

Francesca Elifani, Enrico Amico, Giuseppe Pepe et al. · Human Molecular Genetics · 2019 · 45 citations

Life Sciences, Neurology, Neuroscience +13